- Filed
- Mar 30, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Mar 30, 2022 | 14.02M sh |
| Shares Diluted | FY 2021 · Dec 31, 2020 | 13.76M sh |
| Capex | FY 2021 · Dec 31, 2020 | $200.84K |
| Operating Cash Flow | FY 2021 · Dec 31, 2020 | −$587.33K |
| Cash And Equivalents | FY 2021 · Dec 31, 2020 | $1.13M |
| Current Liabilities | FY 2021 · Dec 31, 2020 | $1.9M |
| Total Liabilities | FY 2021 · Dec 31, 2020 | $5.67M |
| Current Assets | FY 2021 · Dec 31, 2020 | $5.37M |
| Total Assets | FY 2021 · Dec 31, 2020 | $7.03M |
| Eps Diluted | FY 2021 · Dec 31, 2020 | −$0.07 |
| Eps Basic | FY 2021 · Dec 31, 2020 | −$0.07 |
| Sga Expense | FY 2021 · Dec 31, 2020 | $2.54M |
| Net Income | FY 2021 · Dec 31, 2020 | −$898.56K |
| Operating Income restated | FY 2021 · Dec 31, 2020 | −$748.19K |
| Cost Of Revenue | FY 2021 · Dec 31, 2020 | $7.22M |
| Stockholders Equity | FY 2021 · Dec 31, 2019 | $2.02M |